Bradford Teaching Hospitals
NHS Foundation Trust Formulary
Sub Chapters : 08 Malignant disease and immunosuppression
Back to Chapters
Aldesleukin
Alkylating drugs
Amsacrine
Anthracyclines and other cytotoxic antibiotics
Anti-androgens
Anti-lymphocyte monoclonal antibodies
Antimetabolites
Antiproliferative immunosuppressants
Arsenic trioxide
Bevacizumab
Bortezomib
Breast cancer
Brentuximab vedotin
Cetuximab
Corticosteroids and other immunosuppressants
Crisantaspase
Cytotoxic drugs
Dacarbazine and Temozolomide
Drugs for cytotoxic-induced side-effects
Erlotinib
Gonadorelin analogues
Hydroxycarbamide
Immunosuppressant therapy
Interferon Alfa
Natalizumab
Oestrogens
Other antineoplastic drugs
Other immunomodulating drugs
Panitumumab
Pentostatin
Platinum compounds
Procarbazine
Progestogens
Protein kinase inhibitors
Somatostatin analogues
Taxanes
Topoisomerase I inhibitors
Trastuzumab
Tretinoin
Vinca alkaloids and etoposide
Key
Full Site